🏃 Grab this Black Friday offer early. Get up to 55% off InvestingPro now!CLAIM SALE

Johnson & Johnson (JNJ_KZ)

KASE
Currency in USD
155.70
-1.84(-1.17%)
Closed
JNJ_KZ Scorecard
Full Analysis
Has raised its dividend for 54 consecutive years
Fair Value
Day's Range
155.70157.00
52 wk Range
144.20170.00
Key Statistics
Edit
Bid/Ask
155.04 / 155.75
Prev. Close
157.54
Open
157
Day's Range
155.7-157
52 wk Range
144.2-170
Volume
9
Average Volume (3m)
9
1-Year Change
6.29%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
JNJ_KZ Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
174.62
Upside
+14.38%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in oversold territory
Show more

Johnson & Johnson Company Profile

Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company’s Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. Its MedTech segment provides Interventional Solutions, including electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; and neurovascular care that treats hemorrhagic and ischemic stroke. this segment also offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics, ear, nose, and throat procedures; contact lenses under the ACUVUE Brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. The company has a collaboration agreement with Stand Up To Cancer for research testing a combination of teclistamab and daratumumab to treat a rare disease AL amyloidosis. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.

Employees
131900

Compare JNJ_KZ to Peers and Sector

Metrics to compare
JNJ_KZ
Peers
Sector
Relationship
P/E Ratio
25.3x27.0x−0.6x
PEG Ratio
−0.460.330.00
Price/Book
5.3x3.1x2.6x
Price / LTM Sales
4.3x3.0x3.2x
Upside (Analyst Target)
-7.2%43.6%
Fair Value Upside
Unlock24.2%5.8%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 13.88
Dividend Yield
-
Annualised payout
-
5-Years Growth
-
Growth Streak

FAQ

What Is the J&J (JNJ_KZ) Stock Price Today?

The J&J stock price today is 155.70

What Stock Exchange Does J&J Trade On?

J&J is listed and trades on the KASE stock exchange.

What Is the Stock Symbol for J&J?

The stock symbol for J&J is "JNJ_KZ."

What Is the J&J Market Cap?

As of today, J&J market cap is 367.33B.

What is J&J Earnings Per Share?

The J&J EPS is 13.88.

What Is the Next J&J Earnings Date?

J&J will release its next earnings report on 27 Jan 2025.

From a Technical Analysis Perspective, Is JNJ_KZ a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.